Adverse drug reaction reporting via mobile applications: A narrative review.


Journal

International journal of medical informatics
ISSN: 1872-8243
Titre abrégé: Int J Med Inform
Pays: Ireland
ID NLM: 9711057

Informations de publication

Date de publication:
12 2022
Historique:
received: 12 07 2022
revised: 01 10 2022
accepted: 07 10 2022
pubmed: 18 10 2022
medline: 11 11 2022
entrez: 17 10 2022
Statut: ppublish

Résumé

Pharmacovigilance importance has increased in the last few decades and it has led to rise in awareness of adverse drug reaction reporting by both patients and health care professionals. Despite this, research shows reporting practice of health care professionals remains inadequate. Several educational and promotional activities were established in order to improve observed underreporting including the introduction of mobile applications that can be used to report adverse drug reactions. We aimed to review literature on adverse drug reaction reporting applications and whether their introduction improved reporting practice in patients and health care professionals. In this review, we have described several mobile application implementations in different countries. Moreover, we have illustrated some of the applications for particular patients, e.g. patients with multiple sclerosis. All of the included studies showed positive association between application use and ADR reporting. However, there is a great need for future high quality studies to confirm impact of mobile application on ADR reporting.

Identifiants

pubmed: 36252337
pii: S1386-5056(22)00209-X
doi: 10.1016/j.ijmedinf.2022.104895
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104895

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Dario Leskur (D)

Department of Pharmacy, University of Split School of Medicine, Soltanska 2, Split, Croatia.

Josko Bozic (J)

Department of Pathophysiology, University of Split School of Medicine, Soltanska 2, Split, Croatia.

Doris Rusic (D)

Department of Pharmacy, University of Split School of Medicine, Soltanska 2, Split, Croatia.

Ana Seselja Perisin (A)

Department of Pharmacy, University of Split School of Medicine, Soltanska 2, Split, Croatia.

Tin Cohadzic (T)

Department of Pharmacy, University of Split School of Medicine, Soltanska 2, Split, Croatia.

Shelly Pranic (S)

Department of Research in Biomedicine and Health Cochrane Croatia, University of Split School of Medicine, Soltanska 2, Split, Croatia.

Darko Modun (D)

Department of Pharmacy, University of Split School of Medicine, Soltanska 2, Split, Croatia.

Josipa Bukic (J)

Department of Pharmacy, University of Split School of Medicine, Soltanska 2, Split, Croatia. Electronic address: jbukic@mefst.hr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH